Navigation Links
Patient Self-Monitoring: Devices, Markets, Players and Prospects
Date:10/19/2011

NEW YORK, Oct. 19, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Patient Self-Monitoring: Devices, Markets, Players and Prospects

http://www.reportlinker.com/p0581171/Patient-Self-Monitoring-Devices-Markets-Players-and-Prospects .html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings. The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context..

Highlights

• Analyzes and evaluates self-test monitoring technologies and products, and assesses the market potential, commercialization risks and opportunities

• Examines next-generatione monitor technologies, design issues and evolving market factors

• Provides forecasts and market data for self-monitoring products to 2015

• Assesses the impact and influence of self-monitoring enhancements on the healthcare management market

• Profiles self-monitoring market participants, their technology, product development activity, and business strategies

Executive Summary

Disease Management Market Dynamics

Patient Monitoring Overview

Key Factors in Patient Compliance

Market Drivers

Shifting Patient Demographics

Industry Alignment and Competitive Landscape

Self-Monitoring Technology Strategies

Needle-Stick Tests

Dry Chemistry Test Strips

Cassettes

Meters

Self-Collected / Mail-in Tests

Combination Meters

Continuous Monitors

Future Developments

Noninvasive Monitors

Technologies

Optical

Energy-based

Thermal

Signal Processing Advances

Monitor Product Design & Patient Issues

Reliability

Measurement Frequency

Patient/User Interface

Ease-of-Use

Data Collection/Data Display

Continuous vs Discrete Monitoring

Measurement Electronics

Calibration

Accuracy/Precision

Sensitivity

Sensor Technology

Self-Monitoring Therapeutic Segments

Atherosclerosis/Heart Disease (Cholesterol)

Total Cholesterol

Triclycerides

Cholesterol Panel/Lipid Profile

Diabetes (Glucose)

OTC Meters

Alternate Site Testing

Continuous Monitoring

Heart Valve Replacement/Thrombosis

Oral Anticoagulation Therapy

Prothrombin Time

Hypertension (Blood Pressure)

Oscillometric Measurements

Demographic Trends

Self-Monitoring Product Segment Analysis

Cholesterol Monitors

FDA Approved Products

Products in Development

Coagulation Monitoring

FDA Approved Products

Products in Development

Glucose Monitors

Traditional Meters

Needle-stick

Alternate Site Testing

Continuous Monitors

FDA-Approved Monitors

Development-stage Monitors

Noninvasive Glucose Monitors

Combination Monitors

Product Design Factors

FDA Approved Products

Hypertension

Existing Products

Emerging Technologies

Potential/Emerging Self-Monitoring Segments

Market Factors

Clinical Trial Issues

Regulations and Guidance

Managed care/Reimbursement

Patient Compliance

Marketing & Distribution

Sourcing/Private Labeling

Patient Self-Monitoring - Company Profile

To order this report:

: Patient Self-Monitoring: Devices, Markets, Players and Prospects

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... AVIV, Israel , May 19, 2016 ... or the "Company"), an emerging global ophthalmic company focused ... product candidates which address ophthalmic conditions, announced today that ... Italy ) for the manufacturing, distribution, ... product for the treatment of dry eye syndrome (DES) ...
(Date:5/19/2016)... At the 18 th International Leksell Gamma ... , (May 15-19), Elekta announced that Leksell Gamma ... been used in the treatment of more than one ... functional disorders. Today, Gamma Knife surgery is ... hundreds of leading hospitals and clinics around the world. ...
(Date:5/19/2016)... -- The equities market is never short of ... is without doubt the Healthcare space. ActiveWallSt.com has uncovered four ... Alkermes PLC (NASDAQ: ALKS ), AMAG Pharmaceuticals Inc. ... IDXX ), and Atossa Genetics Inc. (NASDAQ: ... http://www.activewallst.com/ On Wednesday, Alkermes PLC,s ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... After graduating from Cornell, author Joshua Alexander ... hospitals, on medication, living on Social Security disability and staying in a group home. ... Beat It!” (published by Balboa Press), Alexander shares how he was finally able to ...
(Date:5/24/2016)... Colorado (PRWEB) , ... May 24, 2016 , ... ... architecture firm, announces the grand opening of ‘El Centro del Quinto Sol Wheel ... of the Pueblo ‘east side’ community to offer something special for this often ...
(Date:5/24/2016)... ... 24, 2016 , ... NutraPre today announced the nationwide release ... to prevent morning sickness and promote overall heath. Engineered with advanced nanotechnology, this ... of water. , “Imagine a pregnancy without morning sickness,” NutraPre CEO Eddie Cameron ...
(Date:5/23/2016)... ... 23, 2016 , ... According to an article published May 12th on the Medical ... health and hygiene. The article points out that, as long as patients are brushing as ... worn and frayed. Of course, these worn-out bristles won’t clean teeth and gum tissue as ...
(Date:5/23/2016)... ... May 23, 2016 , ... The Clinical ... representatives from the Japan PMDA, US FDA, industry and academia at the ... help format data from clinical trials so that it can be shared and ...
Breaking Medicine News(10 mins):